SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001395064-21-000192
Filing Date
2021-09-14
Accepted
2021-09-14 06:13:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A sc13da-091421.htm SC 13D/A 210754
  Complete submission text file 0001395064-21-000192.txt   212391
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Subject) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81377 | Film No.: 211251169
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations